Press Releases May 26, 2026 07:54 PM

SQM Reports Earnings for the Three Months Ended March 31, 2026

SQM Reports Strong Q1 2026 Earnings Driven by Increased Lithium Sales and Upgraded Volume Guidance

By Caleb Monroe SQM

Sociedad Química y Minera de Chile S.A. (SQM) posted robust financial results for Q1 2026 with revenues rising 69.8% year-over-year to $1.76 billion and net income increasing 165.2% to $364.7 million. Strong lithium demand led to increased sales volumes and an upgrade of full-year sales guidance from 10% to 15%. The partnership with CODELCO through Nova Andino Litio and expansion projects like Salar Futuro underpin growth optimism. Other segments such as specialty plant nutrition and iodine also showed positive momentum, supporting a solid outlook for the year.

SQM Reports Earnings for the Three Months Ended March 31, 2026
SQM

Key Points

  • Q1 2026 revenues surged to $1.76 billion, net income rose to $364.7 million, driven by strong lithium sales.
  • Upgraded lithium sales volume guidance from 10% to 15% growth for the full year amid tight supply-demand balance.
  • Expansion projects underway including Salar Futuro and partnership with CODELCO's Nova Andino Litio boost future capacity and revenue streams.
Highlights

  • SQM reported total revenues for the three months ended March 31, 2026 of US$1,760.1 million compared to total revenues of US$1,036.6 million for the same period last year.
  • Net income for the three months ended March 31, 2026 of US$364.7 million or US$1.28 per share, compared to US$137.5 million or US$0.48 per share for the same period last year.
  • In lithium: Strong sales volumes amidst strong market demand. Moving-up sales volumes guidance for the year.
  • In SPN: Stronger than expected quarter in both volumes and prices. Moving-up sales volumes for the year.
 SQM will hold a conference call to discuss these results on Wednesday, May 27, 2026 at 12:00pm EDT (12:00pm Chile time).Participant Call link: https://register-conf.media-server.com/register/BIf194b8fef0d7479a82018f16e2c31fe3Webcast: https://edge.media-server.com/mmc/p/9qtcu4gc


SANTIAGO, Chile, May 26, 2026 (GLOBE NEWSWIRE) -- Sociedad Química y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchange: SQM-B, SQM-A) reported today net income for the three months ended March 31, 2026, of US$364.7 million or US$1.28 per share, an increase of 165.2% compared to US$137.5 million or US$0.48 per share reported for the same period last year.

Gross profit(1) reached US$778.6 million (44.2% of revenues) for the three months ended March 31, 2026, higher than US$304.7 million (29.4% of revenues) recorded for the three months ended March 31, 2025. Revenues totaled US$1,760.1 million for the three months ended March 31, 2026, representing an increase of 69.8% compared to US$1,036.6 million reported for the three months ended March 31, 2025.

SQM’s Chief Executive Officer, Ricardo Ramos, stated, “We delivered strong results during the first quarter of the year. In lithium, sales volumes reached approximately 69 thousand metric tons of LCE across our operations, as we continued to operate at full capacity to meet strong customer demand. Based on our current estimates, global lithium demand could exceed 1.9 million metric tons of LCE this year, while market dynamics continue to suggest a tight supply-demand balance. As a result, we have upgraded our sales volume guidance for the year, increasing our expected growth from 10% to 15%.”

He added, “The first quarter of 2026 marked our first full quarter operating alongside CODELCO through our partnership Nova Andino Litio, and the results underscore the strength of this partnership. We are operating at full capacity, delivering strong financial results, while we continue to expand production capacity. In the first quarter alone, Nova Andino Litio generated more than US$530 million in contributions to the Chilean state, including payments to CORFO, local governments, and taxes.”

“We are currently finalizing the documentation required to begin the environmental permitting process for the Salar Futuro project. We expect to submit the project to the environmental authorities in the coming months and to share further details with the market in the near term. This project will be developed by Nova Andino, and we are very enthusiastic about its potential to establish a new benchmark in lithium production.”

Mr. Ramos continued, “In our SPN business lines, we are also increasing our sales volume guidance for the year. We now expect total sales volumes to grow by approximately 10% compared to last year, driven by tighter supply conditions in Asia. This reflects reduced export availability, as Chinese producers prioritize domestic consumption and scale back potassium nitrate shipments, creating opportunities for us to serve previously undersupplied markets.”

He further noted, “In Iodine, we observed strong sales volumes and higher year-over-year prices, a trend we expect to continue into the next quarter. We are maintaining our full-year sales volume guidance, with volumes expected to be in line with last year. The seawater pipeline is currently in the commissioning phase, and we expect to bring it online during the second half of the year.”

The CEO concluded, “We continue to see positive market dynamics across our key business lines, particularly in lithium, while remaining optimistic about our iodine and specialty plant nutrition segments. We believe we are well positioned to deliver solid results and improved returns to our shareholders, while continuing to advance our expansion plans in both lithium and iodine”

To see full press release please visit: https://ir.sqm.com/


Risks

  • Environmental permitting process for Salar Futuro project may face regulatory delays impacting development timeline.
  • Supply chain and geopolitical risks could affect availability and pricing in lithium and specialty nutrients markets.
  • Market demand fluctuations in Asia, especially reduced potassium nitrate exports from China, could impact SPN business volumes and pricing.

More from Press Releases

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions Jun 4, 2026 Xos Makes Its GFX Debut with Electric Vehicles, Powertrain Technology, and Mobile Charging for Public Fleets Jun 4, 2026 Satellogic to Participate in June Investor Conferences Jun 4, 2026 BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. Jun 4, 2026 SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026 Jun 4, 2026